1. Home
  2. VYNE vs POLA Comparison

VYNE vs POLA Comparison

Compare VYNE & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYNE
  • POLA
  • Stock Information
  • Founded
  • VYNE 2003
  • POLA 1979
  • Country
  • VYNE United States
  • POLA United States
  • Employees
  • VYNE N/A
  • POLA N/A
  • Industry
  • VYNE Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • VYNE Health Care
  • POLA Miscellaneous
  • Exchange
  • VYNE Nasdaq
  • POLA Nasdaq
  • Market Cap
  • VYNE 12.3M
  • POLA 11.5M
  • IPO Year
  • VYNE 2018
  • POLA 2016
  • Fundamental
  • Price
  • VYNE $0.38
  • POLA $2.81
  • Analyst Decision
  • VYNE Buy
  • POLA
  • Analyst Count
  • VYNE 2
  • POLA 0
  • Target Price
  • VYNE $8.00
  • POLA N/A
  • AVG Volume (30 Days)
  • VYNE 1.7M
  • POLA 874.6K
  • Earning Date
  • VYNE 11-06-2025
  • POLA 11-14-2025
  • Dividend Yield
  • VYNE N/A
  • POLA N/A
  • EPS Growth
  • VYNE N/A
  • POLA N/A
  • EPS
  • VYNE N/A
  • POLA N/A
  • Revenue
  • VYNE $524,000.00
  • POLA $11,967,000.00
  • Revenue This Year
  • VYNE N/A
  • POLA N/A
  • Revenue Next Year
  • VYNE N/A
  • POLA N/A
  • P/E Ratio
  • VYNE N/A
  • POLA N/A
  • Revenue Growth
  • VYNE 6.29
  • POLA 0.14
  • 52 Week Low
  • VYNE $0.28
  • POLA $1.53
  • 52 Week High
  • VYNE $4.30
  • POLA $5.75
  • Technical
  • Relative Strength Index (RSI)
  • VYNE 55.03
  • POLA 37.31
  • Support Level
  • VYNE $0.35
  • POLA $3.06
  • Resistance Level
  • VYNE $0.40
  • POLA $3.61
  • Average True Range (ATR)
  • VYNE 0.03
  • POLA 0.35
  • MACD
  • VYNE 0.00
  • POLA -0.11
  • Stochastic Oscillator
  • VYNE 74.75
  • POLA 2.61

About VYNE VYNE Therapeutics Inc.

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Share on Social Networks: